Search Results

• • 6 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study

  Authors:Rafael Mikolajczyk, Johannes Horn, Niklas Schmedt, Ingo Langner, Christina Lindemann, and Edeltraut GarbeFrom:JAMA Pediatrics (Vol. 169, Issue 4) Peer-Reviewed

  Apr. 2015 Report

   Citation Only

• Sodium-Glucose Co-Transporter 2 Inhibitors and the Risk of Venous Thromboembolism in Patients with Type 2 Diabetes: A Cohort Study.

  Authors:Niklas Schmedt, Dirk Enders, Jochen Walker, Edeltraut Garbe, and Antonios DourosFrom:American Journal of Medicine (Vol. 134, Issue 5) Peer-Reviewed

  May 2021454 words Report

   Abstract Only

• Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany

  Authors:Niklas Schmedt, Julia Schiffner-Rohe, Ralf Sprenger, Jochen Walker, Christof von Eiff, and Dennis HacklFrom:PLoS ONE (Vol. 14, Issue 8) Peer-Reviewed

  Aug. 8, 20195,919 words Report 1600LBackground The German Committee on Vaccination recommends pneumococcal vaccination for infants, seniors 60+ years and patients at risk with defined underlying diseases. Aim of this study was to assess the...

• Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data.

  Authors:Christoph Ohlmeier, Holger Gothe, Judith Haas, Ulrike Osowski, Carina Weinhold, Sarah Blauwitz, et al.From:PLoS ONE (Vol. 15, Issue 5) Peer-Reviewed

  May 1, 20206,057 words Article 1470LBackground Multiple Sclerosis (MS) is a chronic inflammatory, immune mediated disease of the central nervous system, with Relapsing Remitting MS (RRMS) being the most common type. Within the last years, the status of...

• Clinical and economic burden of invasive meningococcal disease: Evidence from a large German claims database.

  Authors:Liping Huang, Olivia Denise Heuer, Sabrina Janßen, Dennis Häckl, and Niklas SchmedtFrom:PLoS ONE (Vol. 15, Issue 1) Peer-Reviewed

  Jan. 28, 20206,956 words Article 1640LBackground Limited data is available to describe clinical characteristics, long-term outcomes, healthcare resource use and the attributable costs of invasive meningococcal disease (IMD) in Germany. We aimed to examine...

• Antidepressants and the risk of death in older patients with depression: A population-based cohort study.

  Authors:Bianca Kollhorst, Kathrin Jobski, Jutta Krappweis, Tania Schink, Edeltraut Garbe, and Niklas SchmedtFrom:PLoS ONE (Vol. 14, Issue 4) Peer-Reviewed

  Apr. 15, 20195,267 words Report 1600LBackground Antidepressants are frequently used in older patients with depression, but little is known about the comparative safety of individual agents. The objective of the study was to determine the comparative risk...